Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ozanimod Capsules bulk supplier for pharma manufacturers

Ozanimod Capsules 0.92 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 0.92 mg

Reference Brands: Zeposia(US & EU)

Category: Multiple sclerosis

Ozanimod is a selective S1P receptor modulator that inhibits lymphocyte migration, reducing inflammation in autoimmune diseases. It decreases relapse rates and disease activity in multiple sclerosis and ulcerative colitis. Benefits include oral administration, targeted immune regulation, fewer relapses, and improved quality of life for patients with chronic inflammatory conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ozanimod capsules, marketed as Zeposia, are approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis and ulcerative colitis. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing processes, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional standards for safety and manufacturing.

Ozanimod Capsules — third party manufacturing & bulk supply

Ozanimod Capsules 0.92 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Ozanimod Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ozanimod Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Ozanimod Capsules →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ozanimod Capsules is listed as Capsules in 0.92 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ozanimod Capsules is referenced against Zeposia(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Ozanimod Capsules is catalogued under Multiple sclerosis on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Lamotriginevdispersible Tablets

Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg

Form: Tablets(IR & ER)

Reference Brands: Lamictal, Lamictal XR(EU & US)

View Details
Dalfampridine

Strength:
10 mg

Form: Extended-Release tablets (XR)

Reference Brands: Ampyra(US)

View Details
Tizanidine Tablets/Capsules

Strength:
2 mg and 4 mg

Form: Oral Capsules/Tablets

Reference Brands: Zanaflex (US)

View Details
Baclofen Tablets:

Strength:
10 mg and 20 mg

Form: Tablet

Reference Brands: Lioresal, Gablofen(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.